Grant: Discovery Grants Program - Individual
University of Guelph
$54,000.00
Metabolism of choline, an essential but undervalued nutrient, in cats
EF 2024-25
Résumé
Choline is an essential micronutrient that is critical for proper functioning of liver, muscle, heart, and brain in mammals. It plays a vital role in many physiological and metabolic processes. Choline metabolism results in synthesis of acetylcholine, betaine, phospholipids and trimethylamine. In humans and rodents, choline is related to hepatic lipid accumulation and cognitive and cardiac function. In production animals, choline and betaine decrease fat and improve lean mass gain. Choline is also associated with adverse health outcomes as trimethylamine contributes to cardiovascular and chronic kidney disease risk. Although choline was discovered as an essential nutrient in depancreatized dogs, research investigating choline metabolism and its physiologic and metabolic effects in pets remains in its infancy. Dietary choline recommendations for cats are extrapolated from research in kittens. Adult cat requirements and how these are influenced by energy balance remains largely unexplored. Today, in North America, over 60% of cats are overweight or obese, increasing susceptibility for feline hepatic lipidosis, a common, often fatal liver disease. If dietary choline intake is below requirements, this could further exacerbate liver fat deposition and disease risk. Moreover, with only one report of potential choline toxicosis in cats, little is known about potential adverse effects of choline and its metabolites. My research aims to understand the physiological and metabolic role of choline and its metabolites and to refine feline dietary requirements and pet food formulation. In my previous research, choline reduced food intake and body fat mass without jeopardizing growth in kittens by affecting one-carbon and lipid metabolism. In a dose-response study of overweight cats, choline altered circulating lipid and lipoprotein profiles, suggesting removal of fat from the liver.
Objectives of this proposal include: (1) to investigate choline's physiological and metabolic effects in two energy balance models. In the anabolism model, cats will be fed ad libitum to investigate the role of choline in appetite regulation. In the catabolism model, obese cats will be energy restricted to study choline's effect on body composition, metabolism, cardiac function, inflammation and fecal microbiome. (2) to examine the production of gut microbial-related choline metabolites. Distribution and abundance of key gut bacterial genes encoding enzymes responsible for trimethylamine production will be explored in feline feces and the response of choline and its metabolites to single meals with various forms of choline and its derivatives will be described in cats in the fed and non-fed state.
Understanding choline metabolism and the impact of choline and its metabolites on companion animal physiology will support and eventually provided evidence-based dietary requirements and effective nutrition for cats.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2024-04513
Name nom
Verbrugghe, Adronie
Department département
Clinical Studies - Clinical Studies
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
54000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Metabolism of choline, an essential but undervalued nutrient, in cats
Keywords
animal nutrition; animal metabolism; animal physiology; methyl donor; lipids and lipoproteins; satiety hormones; metabolomics; inflammation; gut microbiome; trimethylamine-n-oxide
Application summary
Choline is an essential micronutrient that is critical for proper functioning of liver, muscle, heart, and brain in mammals. It plays a vital role in many physiological and metabolic processes. Choline metabolism results in synthesis of acetylcholine, betaine, phospholipids and trimethylamine. In humans and rodents, choline is related to hepatic lipid accumulation and cognitive and cardiac function. In production animals, choline and betaine decrease fat and improve lean mass gain. Choline is also associated with adverse health outcomes as trimethylamine contributes to cardiovascular and chronic kidney disease risk. Although choline was discovered as an essential nutrient in depancreatized dogs, research investigating choline metabolism and its physiologic and metabolic effects in pets remains in its infancy. Dietary choline recommendations for cats are extrapolated from research in kittens. Adult cat requirements and how these are influenced by energy balance remains largely unexplored. Today, in North America, over 60% of cats are overweight or obese, increasing susceptibility for feline hepatic lipidosis, a common, often fatal liver disease. If dietary choline intake is below requirements, this could further exacerbate liver fat deposition and disease risk. Moreover, with only one report of potential choline toxicosis in cats, little is known about potential adverse effects of choline and its metabolites. My research aims to understand the physiological and metabolic role of choline and its metabolites and to refine feline dietary requirements and pet food formulation. In my previous research, choline reduced food intake and body fat mass without jeopardizing growth in kittens by affecting one-carbon and lipid metabolism. In a dose-response study of overweight cats, choline altered circulating lipid and lipoprotein profiles, suggesting removal of fat from the liver.
Objectives of this proposal include: (1) to investigate choline's physiological and metabolic effects in two energy balance models. In the anabolism model, cats will be fed ad libitum to investigate the role of choline in appetite regulation. In the catabolism model, obese cats will be energy restricted to study choline's effect on body composition, metabolism, cardiac function, inflammation and fecal microbiome. (2) to examine the production of gut microbial-related choline metabolites. Distribution and abundance of key gut bacterial genes encoding enzymes responsible for trimethylamine production will be explored in feline feces and the response of choline and its metabolites to single meals with various forms of choline and its derivatives will be described in cats in the fed and non-fed state.
Understanding choline metabolism and the impact of choline and its metabolites on companion animal physiology will support and eventually provided evidence-based dietary requirements and effective nutrition for cats.